Emerging Infectious Diseases (Apr 2022)

Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy

  • Isabel Griffin,
  • Kate R. Woodworth,
  • Romeo R. Galang,
  • Veronica K. Burkel,
  • Varsha Neelam,
  • Samantha Siebman,
  • Jerusha Barton,
  • Susan E. Manning,
  • Kathryn Aveni,
  • Nicole D. Longcore,
  • Elizabeth M. Harvey,
  • Van Ngo,
  • Deborah Mbotha,
  • Sarah Chicchelly,
  • Mamie Lush,
  • Valorie Eckert,
  • Paula Dzimira,
  • Ayomide Sokale,
  • Miguel Valencia-Prado,
  • Eduardo Azziz-Baumgartner,
  • Adam MacNeil,
  • Suzanne M. Gilboa,
  • Van T. Tong

DOI
https://doi.org/10.3201/eid2804.212354
Journal volume & issue
Vol. 28, no. 4
pp. 873 – 876

Abstract

Read online

The Surveillance for Emerging Threats to Mothers and Babies Network conducts longitudinal surveillance of pregnant persons in the United States with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection during pregnancy. Of 6,551 infected pregnant persons in this analysis, 142 (2.2%) had positive RNA tests >90 days and up to 416 days after infection.

Keywords